Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 07 2022
14 07 2022
Historique:
received:
19
03
2022
accepted:
04
07
2022
entrez:
14
7
2022
pubmed:
15
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
This is a comprehensive report on immunogenicity of COVAXIN
Identifiants
pubmed: 35835822
doi: 10.1038/s41598-022-16097-3
pii: 10.1038/s41598-022-16097-3
pmc: PMC9281359
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
COVID-19 Vaccines
0
Vaccines, Inactivated
0
Banques de données
ClinicalTrials.gov
['NCT04471519']
CTRI
['CTRI/2021/04/032942']
Types de publication
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
12038Informations de copyright
© 2022. The Author(s).
Références
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Lancet. 2021 Dec 11;398(10317):2173-2184
pubmed: 34774196
Nat Commun. 2022 Jan 24;13(1):460
pubmed: 35075154
Cell Rep Med. 2021 Jul 20;2(7):100354
pubmed: 34250512
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):244-250
pubmed: 32362649
Lancet Infect Dis. 2022 Apr;22(4):430-432
pubmed: 34890538
iScience. 2021 Apr 23;24(4):102298
pubmed: 33723528
EClinicalMedicine. 2021 Jun;36:100915
pubmed: 34095794
Lancet Infect Dis. 2021 Feb;21(2):181-192
pubmed: 33217362
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Lancet Infect Dis. 2021 Jul;21(7):950-961
pubmed: 33705727
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):255-260
pubmed: 32362650
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33772577
N Engl J Med. 2021 Dec 9;385(24):e83
pubmed: 34614327
Lancet Infect Dis. 2022 Apr;22(4):483-495
pubmed: 34890537
JAMA. 2020 Sep 8;324(10):951-960
pubmed: 32789505
Nat Microbiol. 2022 Jul;7(7):974-985
pubmed: 35681012
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Lancet. 2021 Jul 31;398(10298):385-387
pubmed: 34274038
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34002240
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Clin Infect Dis. 2022 Jan 29;74(2):366-368
pubmed: 33961693
Lancet Infect Dis. 2021 May;21(5):637-646
pubmed: 33485468
Euro Surveill. 2021 Oct;26(41):
pubmed: 34651577
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Emerg Microbes Infect. 2021 Dec;10(1):1495-1498
pubmed: 34232116
Diabetes Metab Syndr. 2022 Feb;16(2):102424
pubmed: 35150961
Nat Commun. 2021 Jun 30;12(1):4043
pubmed: 34193870
J Travel Med. 2022 May 31;29(3):
pubmed: 35325176
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
EBioMedicine. 2022 Apr;78:103938
pubmed: 35305396
Lancet Infect Dis. 2022 Jun 16;:
pubmed: 35717995
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nature. 2021 Jul;595(7867):421-425
pubmed: 34030176
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Lancet Infect Dis. 2022 Mar;22(3):349-356
pubmed: 34826383
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432